Brendan Teehan - 17 May 2023 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
EVP, COO, Head of Commercial
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
17 May 2023
Transactions value $
-$334,553
Form type
4
Filing time
19 May 2023, 18:43:20 UTC
Previous filing
03 May 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +14.9K +156.73% 24.4K 17 May 2023 Direct F1
transaction ACAD Common Stock Options Exercise +14.9K +61.05% 39.2K 17 May 2023 Direct F1
transaction ACAD Common Stock Sale -$335K -14.9K -37.91% $22.50 24.4K 17 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -14.9K -37.5% $0.00 24.8K 17 May 2023 Common Stock 14.9K Direct F1, F3
transaction ACAD Restricted Stock Units Options Exercise $0 -14.9K -37.5% $0.00 24.8K 17 May 2023 Common Stock 14.9K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.
F4 The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.